Therapeutic assessment, chemical characterization and in-silico docking of an ethnomedicinal species, Clerodendrum serratum (Linn.) Moon
Abstract
Clerodendrum serratum (Linn.) Moon (CS) is a traditionally well-accepted plant used vigorously in Indian ayurvedic therapeutic purposes. However, not much work has been carried out to prepare its medicinal profile. Moreover, chemical characterization of this plant is still largely unexplored. In the present study, we explored several in-vitro antioxidant methods including hydroxyl radical, nitric oxide, erythrocyte membrane stabilizing activity etc. to evaluate the free radical scavenging potentiality of CS. In addition, GC-MS analysis was performed to identify the active phytocompounds. In-silico docking technique was further employed to examine the binding pattern among selected cancerous proteins (breast cancer, ovarian cancer and lung cancer) and identified active compounds. Result exhibited decent antioxidant activity of CS when compared with respective standards. Furthermore, any drastic metabolic changes were not observed through hemolytic assay confirming CS as a non-toxic stuff and safer to consume. A total number of 6 phytocompounds have been identified via GC-MS analysis in which linoleic acid, oleic acid, squalene and stigmasterol are the main bioactive compounds observed. The in-silico studies disclosed the probable function of selected phytocompounds in neutralizing various types of cancer leading towards new drug discovery.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.